News

Research has found that intensive therapy is not necessarily best when it comes to treating the loss of language and communication in early recovery after a stroke.

Restoring normal patterns of rhythmic neural activity through non-invasive electrical stimulation of the brain alleviates sound-processing deficits and improves reading accuracy in adults with dyslexia, according to a new study.

New research suggests that the brains of older women with Type 2 diabetes do not use as much oxygenated blood as those who don't have the disease. The research is the first to point to changes in blood use in the brain as the primary reason for diabetes-related deficits in motor function.

A new study describes a newly discovered mechanism of learning in the brain shown to stabilize memories and reduce interference between them. Its findings also provide new insight into how humans form expectations and make accurate predictions about what could happen in future.

Research conducted by the Computational Neuroscience Unit at the Okinawa Institute of Science and Technology Graduate University (OIST) has shown for the first time that a computer model can replicate and explain a unique property displayed by a crucial brain cell. Their findings, published today in eLife, shed light on how groups of neurons can self-organize by synchronizing when they fire fast.

Scientists develop a pocket-sized tool for rapidly identifying various mosquito-borne diseases in resource-constrained clinical environments.

Children who are exposed to tobacco have higher rates of hospital admissions after visiting emergency departments or urgent care facilities, according to a new study.

Research approach provides the foundations for scientists to be able to prevent genetically modified organisms (GMOs) from reproducing with wild organisms.

Scientists have detected signs of a frog listed extinct and not seen since 1968, using an innovative technique to locate declining and missing species in two regions of Brazil.

A targeted therapy called capmatinib provides significant benefits to patients who have advanced lung cancer with specific gene mutations, according to the results of a Phase 2 trial.